- Home
- Products
- Customized ADCs
- CD33
- Anti-CD33mAb-DOTA-SH ADC
Anti-CD33mAb-DOTA-SH ADC (CAT#: ADC-W-360)
This ADC product is comprised of an anti-CD33 monoclonal antibody conjugated via a DOTA-SH linker to a drug.
- Product Information
- ADC Target
- ADC Antibody
- ADC Linker
- Antibody clone #
- HuM195
- Name
- CD33
- Alternative Names
- CD33; CD33 molecule; p67; SIGLEC3; SIGLEC-3; myeloid cell surface antigen CD33; gp67; CD33 antigen (gp67); sialic acid binding Ig-like lectin 3; sialic acid-binding Ig-like lectin 3;
- Target Entrez Gene ID
- 945
- Target UniProt ID
- P20138
- Overview
- CD33 or Siglec-3 is a transmembrane receptor expressed on cells of myeloid lineage. It is usually considered myeloid-specific, but it can also be found on some lymphoid cells. It binds sialic acids, therefore is a member of the SIGLEC family of lectins.
- Overview
- Humanized Anti-CD33 lgG1 Antibody, clone # HuM195
- Clone #
- HuM195
- Species Reactivity
- Human
- Name
- DOTA-SH
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-TNFRSF8 (Brentuximab )-SMCC-DM1 ADC (CAT#: ADC-W-2343)
- Anti-IL23A (Tildrakizumab)-MC-MMAF ADC (CAT#: ADC-W-1354)
- Anti-CD3D (Teplizumab)-SPDB-DM4 ADC (CAT#: ADC-W-831)
- Anti-EFNA4-AcBut-CM ADC-1 (CAT#: ADC-W-018)
- Anti-MS4A1 (Tositumomab)-MC-Vc-PAB-SN38 ADC (CAT#: ADC-W-1584)
- Anti-TNFRSF13B (Tabalumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (CAT#: ADC-W-1909)
- Anti-DLL3-PBD dimers ADC-4 (CAT#: ADC-W-106)
- Anti-CA9-VC-MMAE ADC (CAT#: ADC-W-475)
- Anti-EGFR-doxorubicin ADC (CAT#: ADC-W-600)
- Anti-CD3E (Visilizumab)-MC-Vc-PAB-SN38 ADC (CAT#: ADC-W-846)
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for ADC-W-360. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
| CAT# | Product Name | Linker | Payload |
| ADC-W-2538 | Anti-CD33 (Gemtuzumab)-SPDB-DM4 ADC | SPDB (N-succinimidyl-4-(2-pyridyldithio)butyrate) | DM4 (N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine) |
| ADC-W-815 | Anti-CD33 (Lintuzumab)-MC-Vc-PAB-MMAE ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE |
| ADC-W-464 | Anti-CD33-AcBut-Calicheamicin ADC-5 | AcBut (4-(4-acetylphenoxy)butanoic acid) | Calicheamicin |
| ADC-W-2537 | Anti-CD33 (Gemtuzumab)-SMCC-DM1 ADC | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine) |
| ADC-W-2540 | Anti-CD33 (Gemtuzumab)-MC-Vc-PAB-MMAE ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE |
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
